Aratana Therapeutics Inc (PETX)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart
Ticker: PETX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2019-02-01 2019-01-30 PS Planned sale

AYRES JOHN C

SEE REMARKS

Officer
3,125 -2.3%
4.19
13,094 USD 		3,125 -2.3% 4.19 13,094 USD
2018-12-17 2018-12-17 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
46,094 -8.2%
5.85
269,788 USD 		46,094 -8.2% 5.85 269,788 USD
2018-11-09 2018-11-07 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
19,308 -12.5%
6.95
134,191 USD 		19,308 -12.5% 6.95 134,191 USD
2018-11-06 2018-11-02 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
692 -0.4%
6.95
4,809 USD 		692 -0.4% 6.95 4,809 USD
2018-10-31 2018-10-30 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
11,513 -2.0%
5.86
67,454 USD 		11,513 -2.0% 5.86 67,454 USD
2018-09-21 2018-09-21 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
75,000 -11.6%
6.06
454,305 USD 		75,000 -11.6% 6.06 454,305 USD
2018-08-14 2018-08-14 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
1,712 -1.1%
5.15
8,817 USD 		1,712 -1.1% 5.15 8,817 USD
2018-08-14 2018-08-13 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
8,660 -5.2%
5.15
44,599 USD 		8,660 -5.2% 5.15 44,599 USD
2018-08-10 2018-08-10 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
1,954 -1.2%
5.15
10,063 USD 		1,954 -1.2% 5.15 10,063 USD
2018-08-10 2018-08-08 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
2,674 -1.6%
5.15
13,771 USD 		2,674 -1.6% 5.15 13,771 USD
2018-07-30 2018-07-30 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
11,513 -1.7%
4.33
49,842 USD 		11,513 -1.7% 4.33 49,842 USD
2018-06-27 2018-06-25 PS Planned sale

Standridge Brent

Chief Operating Officer

Officer
10,000 -9.1%
4.56
45,644 USD 		10,000 -9.1% 4.56 45,644 USD
2018-02-01 2018-01-30 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
19,367 -2.8%
4.77
92,301 USD 		19,367 -2.8% 4.77 92,301 USD
2018-01-12 2018-01-11 PS Planned sale

TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
30,000 -28.6%
5.27
158,040 USD 		30,000 -28.6% 5.27 158,040 USD
2017-12-01 2017-12-01 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
425,298 -9.0%
5.40
2,296,609 USD 		425,298 -9.0% 5.40 2,296,609 USD
2017-12-01 2017-12-01 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
1,900 -0.0%
5.44
10,336 USD 		1,900 -0.0% 5.44 10,336 USD
2017-12-01 2017-12-01 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
50,000 -1.0%
5.45
272,500 USD 		50,000 -1.0% 5.45 272,500 USD
2017-12-01 2017-12-01 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
100 -0.0%
5.47
547 USD 		100 -0.0% 5.47 547 USD
2017-12-01 2017-12-01 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
5,110 -0.1%
5.52
28,207 USD 		5,110 -0.1% 5.52 28,207 USD
2017-12-01 2017-12-01 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
8,020 -0.2%
5.53
44,351 USD 		8,020 -0.2% 5.53 44,351 USD
2017-12-01 2017-12-01 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
72,000 -1.5%
5.65
406,800 USD 		72,000 -1.5% 5.65 406,800 USD
2017-12-01 2017-11-30 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
50,000 -1.0%
5.90
295,000 USD 		50,000 -1.0% 5.90 295,000 USD
2017-12-01 2017-11-30 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
50,000 -1.0%
5.95
297,500 USD 		50,000 -1.0% 5.95 297,500 USD
2017-12-01 2017-11-30 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
100,000 -2.0%
5.95
595,000 USD 		100,000 -2.0% 5.95 595,000 USD
2017-12-01 2017-11-30 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
11,472 -0.2%
5.97
68,488 USD 		11,472 -0.2% 5.97 68,488 USD
2017-12-01 2017-11-30 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
100 -0.0%
6.03
603 USD 		100 -0.0% 6.03 603 USD
2017-12-01 2017-11-29 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
1,900 -0.0%
6.26
11,894 USD 		1,900 -0.0% 6.26 11,894 USD
2017-12-01 2017-11-29 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
300 -0.0%
6.28
1,884 USD 		300 -0.0% 6.28 1,884 USD
2017-12-01 2017-11-29 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
7,700 -0.2%
6.35
48,895 USD 		7,700 -0.2% 6.35 48,895 USD
2017-12-01 2017-11-29 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
50,000 -1.0%
6.50
325,000 USD 		50,000 -1.0% 6.50 325,000 USD
2017-12-01 2017-11-29 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
5,751 -0.1%
6.55
37,669 USD 		5,751 -0.1% 6.55 37,669 USD
2017-12-01 2017-11-29 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
49,865 -1.0%
6.60
329,109 USD 		49,865 -1.0% 6.60 329,109 USD
2017-12-01 2017-11-29 S Sale

Broadfin Healthcare Master Fund Ltd

Large shareholder
1,000 -0.0%
6.66
6,660 USD 		1,000 -0.0% 6.66 6,660 USD
2017-11-13 2017-11-10 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -8.6%
7.00
350,000 USD 		50,000 -8.6% 7.00 350,000 USD
2017-10-04 2017-10-02 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.9%
6.24
312,115 USD 		50,000 -7.9% 6.24 312,115 USD
2017-09-27 2017-09-25 PS Planned sale

Standridge Brent

Chief Operating Officer
10,000 -12.5%
6.11
61,127 USD 		10,000 -12.5% 6.11 61,127 USD
2017-09-19 2017-09-15 PS Planned sale

HEINEN ERNST

Chief Development Officer
10,000 -7.1%
6.25
62,500 USD 		10,000 -7.1% 6.25 62,500 USD
2017-04-18 2017-04-17 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.9%
5.54
277,150 USD 		50,000 -7.9% 5.54 277,150 USD
2017-01-31 2017-01-27 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.3%
7.72
385,875 USD 		50,000 -7.3% 7.72 385,875 USD
2016-12-16 2016-12-15 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -8.4%
7.63
381,380 USD 		50,000 -8.4% 7.63 381,380 USD
2016-10-04 2016-10-03 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
10,000 -8.0%
10.00
100,006 USD 		10,000 -8.0% 10.00 100,006 USD
2016-09-12 2016-09-09 PS Planned sale

TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
30,000 -29.3%
9.25
277,599 USD 		30,000 -29.3% 9.25 277,599 USD
2016-08-10 2016-08-09 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.2%
9.25
462,500 USD 		50,000 -7.2% 9.25 462,500 USD
2016-06-28 2016-06-28 PS Planned sale

STEPHANUS JULIA A

CHIEF COMMERCIAL OFFICER

Officer
30,000 -19.0%
6.25
187,500 USD 		30,000 -19.0% 6.25 187,500 USD
2016-06-17 2016-06-17 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
25,000 -3.5%
6.32
158,020 USD 		25,000 -3.5% 6.32 158,020 USD
2016-06-17 2016-06-16 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
75,000 -9.5%
6.24
468,293 USD 		75,000 -9.5% 6.24 468,293 USD
2016-06-13 2016-06-10 PS Planned sale

HEINEN ERNST

Chief Development Officer

Officer
15,000 -10.7%
6.72
100,862 USD 		15,000 -10.7% 6.72 100,862 USD
2016-02-02 2016-02-01 PS Planned sale

TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
2,806 -2.7%
3.36
9,436 USD 		2,806 -2.7% 3.36 9,436 USD
2015-04-28 2015-04-27 PS Planned sale

Rhodes Linda

CHIEF SCIENTIFIC OFFICER

Officer
3,300 -0.8%
15.78
52,073 USD 		3,300 -0.8% 15.78 52,073 USD
2015-04-28 2015-04-27 PS Planned sale

Rhodes Linda

CHIEF SCIENTIFIC OFFICER

Officer
11,700 -2.7%
14.78
172,912 USD 		11,700 -2.7% 14.78 172,912 USD
2015-01-06 2015-01-02 PS Planned sale

St Peter Steven

PRESIDENT AND CEO

Executive Director
25,000 -3.5%
17.87
446,648 USD 		25,000 -3.5% 17.87 446,648 USD
2014-03-12 2014-03-10 S Sale

MPM BIOVENTURES V, L.P.

Large shareholder
600,000 -17.9%
20.02
12,012,000 USD 		600,000 -17.9% 20.02 12,012,000 USD
2014-03-11 2014-03-07 S Sale

Foley Todd

Large shareholder
12,539 -100.0%
19.95
250,153 USD 		12,539 -100.0% 19.95 250,153 USD
2014-03-11 2014-03-07 S Sale

GADICKE ANSBERT

Large shareholder
26,713 -100.0%
20.16
538,534 USD 		26,713 -100.0% 20.16 538,534 USD
2014-02-05 2014-02-03 S Sale

MEEUSEN RONALD L

Non-Executive Director
45,100 -37.4%
19.00
856,900 USD 		45,100 -37.4% 19.00 856,900 USD
2014-02-05 2014-02-03 S Sale

MEEUSEN RONALD L

Non-Executive Director
454,900 -37.4%
19.00
8,643,100 USD 		454,900 -37.4% 19.00 8,643,100 USD
2014-02-05 2014-02-03 S Sale

Avalon Ventures IX, L.P.

Large shareholder
825,000 -19.8%
19.00
15,675,000 USD 		825,000 -19.8% 19.00 15,675,000 USD
2014-02-05 2014-02-03 S Sale

Lichter Jay

Non-Executive Director Large shareholder
825,000 -19.8%
19.00
15,675,000 USD 		825,000 -19.8% 19.00 15,675,000 USD
2013-07-03 2013-07-02 B Purchase

St Peter Steven

PRESIDENT AND CEO

Executive Director
8,333 +1.6%
6.00
49,998 USD 		8,333 +1.6% 6.00 49,998 USD
2013-07-03 2013-07-02 B Purchase

STEPHANUS JULIA A

CHIEF COMMERCIAL OFFICER

Officer
2,000 +1.5%
6.00
12,000 USD 		2,000 +1.5% 6.00 12,000 USD
2013-07-02 2013-07-02 B Purchase

Vander Vort John

Non-Executive Director Large shareholder
500,000 +13.0%
6.00
3,000,000 USD 		500,000 +13.0% 6.00 3,000,000 USD
2013-07-02 2013-07-02 B Purchase

MPM BIOVENTURES V, L.P.

Large shareholder
500,000 +13.0%
6.00
3,000,000 USD 		500,000 +13.0% 6.00 3,000,000 USD